Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹7 Cr
P/E Ratio
--
P/B Ratio
-3.62
Industry P/E
36.27
Debt to Equity
-0.87
ROE
0 %
ROCE
0 %
Div. Yield
0 %
Book Value
-3.47
EPS
-0.6
CFO
₹-7.64 Cr
EBITDA
₹-0.99 Cr
Net Profit
₹-8.64 Cr
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Adline Chem Lab
| -43.51 | -5.20 | -34.19 | -- | 20.30 | 20.06 | -- |
BSE Healthcare
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
BSE Small Cap
| -12.38 | 0.32 | -4.19 | 2.45 | 17.96 | 35.18 | 15.87 |
2022
|
|
---|---|
Adline Chem Lab
| -25.78 |
BSE Small Cap
| -1.80 |
BSE Healthcare
| -12.10 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
---|---|---|---|---|
735.15 | 6,661.19 | 26.72 | 13.8 | |
1,069.80 | 8,742.78 | 72.03 | 12.96 | |
452.55 | 10,967.83 | 22.89 | 14.4 | |
884.20 | 5,068.41 | 39.78 | 14.76 |
No Review & Analysis are available.
Kamron Laboratories Ltd markets pharmaceutical products, and nutraceuticals and dietary supplements in India and internationally. It provides tablets, capsules, and injections. The company provides its products for anti-anxiety, anti-infective, bone... health, gastroentology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care, and hepatocare. It also offers veterinary products and educational supplements. The company was founded in 1988 and is based in Gandhinagar, India. Read more
Incorporated
1988
Chairman
--
Managing Director
Sarang Pathak
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Adline Chem Lab Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
The total asset value of Adline Chem Lab Ltd stood at ₹ 0 Cr as on 31-Dec-24
The share price of Adline Chem Lab Ltd is ₹12.57 (BSE) as of 25-Apr-2025 IST. Adline Chem Lab Ltd has given a return of 20.3% in the last 3 years.
Adline Chem Lab Ltd has a market capitalisation of ₹ 7 Cr as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Adline Chem Lab Ltd is -3.62 times as on 25-Apr-2025, a 200% discount to its peers’ median range of 3.63 times.
Since, TTM earnings of Adline Chem Lab Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Adline Chem Lab Ltd and enter the required number of quantities and click on buy to purchase the shares of Adline Chem Lab Ltd.
Kamron Laboratories Ltd markets pharmaceutical products, and nutraceuticals and dietary supplements in India and internationally. It provides tablets, capsules, and injections. The company provides its products for anti-anxiety, anti-infective, bone health, gastroentology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care, and hepatocare. It also offers veterinary products and educational supplements. The company was founded in 1988 and is based in Gandhinagar, India.
The promoter of Adline Chem Lab Ltd is Hemant Amrish Parikh. Hemant Amrish Parikh owns 25.85 per cent of the total equity. The chairman of the company is , and the managing director is Sarang Pathak..
There is no promoter pledging in Adline Chem Lab Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
10,968
|
|
8,743
|
|
6,661
|
|
5,068
|
Adline Chem Lab Ltd. | Ratios |
---|---|
Return on equity(%)
|
--
|
Operating margin(%)
|
--
|
Net Margin(%)
|
-1303.7
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Adline Chem Lab Ltd was ₹0 Cr.